Venmax Drugs & Pharmaceuticals Shareholding Pattern

As of Mar 2026, Venmax Drugs & Pharmaceuticals (VENMAX) promoter holding 13.80%, FII 0.00%, DII 0.00%, public 66.29%, total shareholders 6,802. Review VENMAX P/E comparison to evaluate earnings-based valuation against sector peers.

Promoter Holding 13.80%
FII Holding 0.00%
DII Holding 0.00%
Public Holding 66.29%
Total Shareholders 6,802
As of Mar 2026

VENMAX Recent Shareholding Changes — Promoter, FII & DII

Venmax Drugs & Pharmaceuticals promoter, FII and DII holding change from Dec 2025 to Mar 2026 — promoter -1.34%. For live price, key ratios and the full company profile, see VENMAX stock price BSE.

Promoter Holding Change
Dec 2025 to Mar 2026
-1.34%
FII Holding Change
Dec 2025 to Mar 2026
No Change
DII Holding Change
Dec 2025 to Mar 2026
No Change
Public Holding Change
Dec 2025 to Mar 2026
+2.04%

Venmax Drugs & Pharmaceuticals Quarterly Shareholding Trend — Promoter, FII, DII & Public

VENMAX promoter, FII, DII, public and government holding % by quarter — institutional ownership and promoter pledge trends. Check VENMAX market cap trends to track the company's total market size over time.

Promoter
FII
DII
Public
Government

VENMAX Shareholding Pattern Data — Quarterly History

Venmax Drugs & Pharmaceuticals quarterly promoter, FII, DII, public holding % and total shareholders. Download as Excel or CSV.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 13.80% 0.00% 0.00% 0.00% 66.29% 19.91% 100.00% 6,802
Dec 2025 15.14% 0.00% 0.00% 0.00% 64.25% 20.61% 100.00% 6,815
Sept 2025 23.14% 0.00% 0.00% 0.00% 65.36% 11.51% 100.01% 6,764
Jun 2025 23.14% 0.00% 0.00% 0.00% 65.01% 11.86% 100.01% 6,729
Mar 2025 23.14% 0.00% 0.15% 0.00% 65.24% 11.47% 100.00% 6,756
Dec 2024 23.14% 0.00% 0.15% 0.00% 65.54% 11.17% 100.00% 6,657
Sept 2024 23.14% 0.00% 0.15% 0.00% 65.67% 11.04% 100.00% 6,291
Jun 2024 23.14% 0.00% 0.15% 0.00% 65.66% 11.06% 100.01% 6,252
Mar 2024 23.14% 0.00% 0.15% 0.00% 65.66% 11.06% 100.01% 6,251
Dec 2023 23.14% 0.00% 0.15% 0.00% 65.66% 11.06% 100.01% 6,252
Sept 2023 23.14% 0.00% 0.15% 0.00% 65.66% 11.06% 100.01% 6,250
Jun 2023 23.14% 0.00% 0.15% 0.00% 65.66% 11.06% 100.01% 6,250
Mar 2023 23.14% 0.00% 0.15% 0.00% 65.64% 11.07% 100.00% 6,251
Dec 2022 23.14% 0.00% 0.15% 0.00% 65.64% 11.07% 100.00% 6,253
Sept 2022 23.14% 0.00% 0.15% 0.00% 65.64% 11.07% 100.00% 6,255
Jun 2022 23.14% 0.00% 0.15% 0.00% 65.57% 11.15% 100.01% 6,255
Mar 2022 23.14% 0.00% 0.15% 0.00% 65.57% 11.15% 100.01% 6,256
Dec 2021 23.14% 0.00% 0.15% 0.00% 65.57% 11.15% 100.01% 6,257
Sept 2021 23.14% 0.00% 0.15% 0.00% 65.57% 11.15% 100.01% 6,261
Jun 2021 23.14% 0.00% 0.15% 0.00% 65.69% 11.03% 100.01% 6,261
Mar 2021 23.14% 0.00% 0.15% 0.00% 65.69% 11.03% 100.01% 0
Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 13.80% 0.00% 0.00% 0.00% 66.29% 19.91% 100.00% 6,802
Dec 2025 15.14% 0.00% 0.00% 0.00% 64.25% 20.61% 100.00% 6,815
Sept 2025 23.14% 0.00% 0.00% 0.00% 65.36% 11.51% 100.01% 6,764
Jun 2025 23.14% 0.00% 0.00% 0.00% 65.01% 11.86% 100.01% 6,729
Mar 2025 23.14% 0.00% 0.15% 0.00% 65.24% 11.47% 100.00% 6,756
Dec 2024 23.14% 0.00% 0.15% 0.00% 65.54% 11.17% 100.00% 6,657
Sept 2024 23.14% 0.00% 0.15% 0.00% 65.67% 11.04% 100.00% 6,291
Jun 2024 23.14% 0.00% 0.15% 0.00% 65.66% 11.06% 100.01% 6,252
Mar 2024 23.14% 0.00% 0.15% 0.00% 65.66% 11.06% 100.01% 6,251
Dec 2023 23.14% 0.00% 0.15% 0.00% 65.66% 11.06% 100.01% 6,252
Sept 2023 23.14% 0.00% 0.15% 0.00% 65.66% 11.06% 100.01% 6,250
Jun 2023 23.14% 0.00% 0.15% 0.00% 65.66% 11.06% 100.01% 6,250
Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 13.80% 0.00% 0.00% 0.00% 66.29% 19.91% 100.00% 6,802
Dec 2025 15.14% 0.00% 0.00% 0.00% 64.25% 20.61% 100.00% 6,815
Dec 2024 23.14% 0.00% 0.15% 0.00% 65.54% 11.17% 100.00% 6,657
Dec 2023 23.14% 0.00% 0.15% 0.00% 65.66% 11.06% 100.01% 6,252
Dec 2022 23.14% 0.00% 0.15% 0.00% 65.64% 11.07% 100.00% 6,253
Dec 2021 23.14% 0.00% 0.15% 0.00% 65.57% 11.15% 100.01% 6,257